CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Warnex Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Warnex Inc.
Suite 200, 1375 TransCanada Highway
Phone: (450) 663-6724p:450 663-6724 DORVAL, QC  H9P 2W8  Canada Ticker: WNXX WNXX

This company was Merged or Acquired on 7/8/2014.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Warnex Inc. is a life sciences company engaged in providing diverse laboratory services. The Company offers analytical services to the pharmaceutical sector. Its analytical Services provide quality control services to the pharmaceutical and biotechnology industries, including chemistry, chromatography, microbiology, method development and validation, and stability studies. The Company sold the assets of its Medical Laboratories division to Gamma-Dynacare Medical Laboratories. It sold its Analytical Services division to NEOPHARM LABS Inc. The Company sold its Bioanalytical Services division to Biotrial Research S.A.S. In July 2014, Diagnos Inc announced the completion of the merger of Warnex Inc. with the wholly owned subsidiary of Diagnos Inc.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201412/31/2013Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board MichaelSinger 48 4/20/2012 6/30/2011
Interim Chief Executive Officer, Chief Financial Officer, Director SeanKaramchandani 5/29/2013 5/29/2013
Independent Director Joseph A.Walewicz 6/30/2011 6/30/2011

Business Names
Business Name
Molecular World Inc.
WNXX

General Information
Number of Employees: 250 (As of 12/31/2010)
Outstanding Shares: 28,323,884 (As of 3/31/2014)
Stock Exchange: NEX
Fax Number: (450) 669-2784


Copyright © 2021 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 2, 2021